What is The Oncology Institute, Inc.'s change in receivables?

The Oncology Institute, Inc. (TOI) reported change in receivables of $994K in Q1 2026.

What is the long-term trend for The Oncology Institute, Inc.'s change in receivables?

Over 2 years (2021 to 2025), The Oncology Institute, Inc.'s change in receivables has grown at a -41.9% compound annual growth rate (CAGR), from $863K to $291K.

What does change in receivables mean?

Change in total receivables including trade and non-trade receivables.

The Oncology Institute, Inc. TOI Change in receivables

Change in receivables at other companies

McKessonMCK

$207M-85.2%

Option Care Health, Inc.OPCH

$42.87M-24.5%

Inhibrx Biosciences, Inc.INBX

$9K-47.1%

Bristol-Myers SquibbBMY

-$1.69B-11,147%

Eli LillyLLY

$1.75B+225%

Other financials

Income statement

See full

Revenue$147.4M+41.2%

Operating income-$6.5M+34.3%

Net income-$2.5M+87.3%

EPS (diluted)-$0.02+90.5%

Balance sheet

See full

Cash & equivalents$30.3M-23.8%

Total debt$104.9M+2.5%

Total equity-$16.3M-421%

Total assets$168.2M+2.6%

Cash flow

See full

Operating cash flow-$2.2M+55.6%

CapEx$1.0M+218%

Free cash flow-$3.3M+38.7%

Valuation

See full

Market cap$511.91M+133%

Enterprise value$586.58M+108%

P/S0.9×+0.4×

Profitability

See full

Operating margin-6%-2.1pp

Net margin-8%-2.7pp

FCF margin-5.1%—

Returns & leverage

See full

Return on equity-277.6%-700pp

Debt / equity20.2×+17.3×

Current ratio1.5×-0.3×

Where this comes from

Reported directly by The Oncology Institute, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherReceivables.

The official record: The Oncology Institute, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about The Oncology Institute, Inc.'s change in receivables.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is The Oncology Institute, Inc.'s change in receivables?: The Oncology Institute, Inc. (TOI) reported change in receivables of $994K in Q1 2026.
What is the long-term trend for The Oncology Institute, Inc.'s change in receivables?: Over 2 years (2021 to 2025), The Oncology Institute, Inc.'s change in receivables has grown at a -41.9% compound annual growth rate (CAGR), from $863K to $291K.
What does change in receivables mean?: Change in total receivables including trade and non-trade receivables.